136862-90-3

Upstream product

• 212912-47-5 2RS,4S,5R-4-Methyl-3-p-methylphenylsulphonyl-2-methoxy-5-phenyl-1,3-oxazolidine 
• 133319-48-9 (2E)-1-(Benzyloxymethyloxy)-2-butenyl(tri-n-butyl)stannane 
• 136983-04-5 ((Z)-3-Benzyloxymethoxy-1-methyl-allyl)-tributyl-stannane 

Downstream Products

• 1025933-13-4 (E)-(R)-1-[(2R,4S,5R)-4-Methyl-5-phenyl-3-(toluene-4-sulfonyl)-oxazolidin-2-yl]-but-2-en-1-ol 
• 133732-88-4 (2R,4S,5R)-2-((R)-1,2-Bis-benzyloxy-ethyl)-4-methyl-5-phenyl-3-(toluene-4-sulfonyl)-oxazolidine 
• 136862-94-7 (R)-2-Benzyloxymethoxy-2-[(2R,4S,5R)-4-methyl-5-phenyl-3-(toluene-4-sulfonyl)-oxazolidin-2-yl]-ethanol 
• 136862-95-8 (R)-1-[(2R,4S,5R)-4-Methyl-5-phenyl-3-(toluene-4-sulfonyl)-oxazolidin-2-yl]-ethane-1,2-diol 

Relevant academic research and scientific papers

Addition of Racemic Alkoxyallylstannanes to an Enantiomerically Pure 2-Methoxyoxazolidine: An Example of Combined Mutual Diastereoface Selection and Kinetic Resolution

The BF3*Et2O-promoted addition of racemic α- and γ-alkoxyallylstannanes 2 or 3 to the 2-methoxyoxazolidine 1 afforded adducts 4 and 5 in diastereomeric ratios up to 95:5 accompanied by enantioenriched γ-stannanes (R)-3.This behavior is consistent with a f